Recombinant Mouse ADP/ATP translocase 1 (Slc25a4)

Molecular Structure and Characteristics

ADP/ATP translocase 1, encoded by the Slc25a4 gene (human ortholog SLC25A4), is a member of the mitochondrial carrier subfamily of solute carrier proteins. This protein forms a homodimeric complex embedded within the inner mitochondrial membrane, where it functions as a gated pore for the exchange of adenine nucleotides . The mouse Slc25a4 protein shares significant homology with its human counterpart and is also known by several synonyms including ADP, ATP carrier protein 1, adenine nucleotide translocator 1, ANT1, and mANC1 . As a member of the larger mitochondrial carrier family, Slc25a4 exhibits the characteristic structural features that enable selective transport across the mitochondrial inner membrane while maintaining the crucial electrochemical gradient necessary for oxidative phosphorylation.

The protein contains multiple transmembrane domains that create a channel through which adenine nucleotides can pass. This specific arrangement allows for the precise control of metabolite movement between the mitochondrial matrix and the cytoplasm. The functional importance of Slc25a4 is highlighted by its high conservation across species, reflecting the fundamental role it plays in cellular bioenergetics. The recombinant form of mouse Slc25a4 produced for research purposes maintains these structural characteristics, enabling detailed investigation of its functions in controlled experimental systems.

Physiological Function

The primary physiological function of Slc25a4 is to catalyze the exchange of cytoplasmic ADP with mitochondrial ATP across the inner mitochondrial membrane . This exchange is fundamental to cellular energy metabolism, as it provides ATP synthesized in the mitochondria to the cytoplasm for cellular processes while simultaneously supplying ADP to the mitochondrial matrix for continued ATP production via oxidative phosphorylation. This bidirectional transport mechanism creates a cycle that sustains energy production and utilization throughout the cell.

Interestingly, Slc25a4 also exhibits dual transport functions beyond nucleotide exchange. Research indicates that it can function as a proton transporter, contributing to mitochondrial uncoupling and thermogenesis . This proton transport activity is inhibited by its ADP/ATP antiporter activity, suggesting that Slc25a4 acts as a master regulator of mitochondrial energy output by maintaining a delicate balance between ATP production and heat generation . Additionally, studies have revealed that Slc25a4 plays a role in the mitochondrial permeability transition pore (mPTP) opening, although its exact contribution—whether as a pore-forming component or a regulator—remains under investigation .

Significance in Mitochondrial Biology

Beyond its direct role in bioenergetics, Slc25a4 has emerged as a crucial player in broader aspects of mitochondrial biology. Recent research has uncovered its unexpected involvement in mitophagy, the selective degradation of damaged mitochondria. Surprisingly, this function appears to be independent of its nucleotide translocase activity . The protein interacts with components of the mitochondrial import machinery, particularly the TIM23 complex and TIM44, to regulate the stabilization of PINK1, a kinase essential for initiating mitophagy in response to mitochondrial damage .

Expression Systems

The production of recombinant mouse Slc25a4 typically involves advanced expression systems capable of generating properly folded membrane proteins. While the search results don't provide specific details about the expression systems used for mouse Slc25a4, membrane proteins like translocases are commonly expressed in eukaryotic systems such as yeast or insect cells using baculovirus expression vectors. These systems offer advantages for membrane protein production compared to bacterial systems, as they provide a eukaryotic membrane environment and post-translational modification machinery more similar to that of mammalian cells.

For research applications, recombinant Slc25a4 is produced with various tags to facilitate purification and detection. These tags can include polyhistidine (His) tags, FLAG tags, or other affinity tags that enable selective isolation of the target protein from the complex mixture of cellular components. The expression conditions are typically optimized to balance protein yield with proper folding and functionality, as membrane proteins often present challenges in recombinant production due to their hydrophobic nature and complex topology.

Purification Techniques

After expression, recombinant mouse Slc25a4 must be carefully extracted from cellular membranes and purified to homogeneity while maintaining its native structure and function. This process typically begins with selective membrane solubilization using detergents that can extract the protein from the lipid bilayer without causing denaturation. Common detergents used for mitochondrial carrier proteins include mild non-ionic detergents such as n-dodecyl-β-D-maltoside (DDM) or digitonin.

Following solubilization, the protein is purified using affinity chromatography that targets the engineered tags on the recombinant protein. Additional purification steps may include ion exchange chromatography, size exclusion chromatography, or other techniques to achieve high purity. Throughout the purification process, care must be taken to maintain the protein in a stable buffer environment that preserves its structural integrity and functional properties. The purified recombinant Slc25a4 can then be used directly for biochemical and functional studies or reconstituted into artificial membrane systems such as liposomes for transport assays.

Quality Control and Verification

To ensure the reliability of experimental results, recombinant mouse Slc25a4 undergoes rigorous quality control and verification procedures. These typically include assessment of protein purity by SDS-PAGE, Western blotting with specific antibodies, and mass spectrometry analysis to confirm protein identity. The oligomeric state of the purified protein is often evaluated using techniques such as native gel electrophoresis, analytical ultracentrifugation, or size exclusion chromatography coupled with multi-angle light scattering.

Functional verification is particularly important for transport proteins like Slc25a4. This can involve measuring ADP/ATP exchange activity using either radioactive substrates or fluorescence-based assays, as described in the search results . The specific inhibition of transport activity by known inhibitors such as bongkrekic acid and carboxyatractyloside serves as a valuable control to confirm that the purified recombinant protein retains its native functional properties . These quality control measures ensure that the recombinant mouse Slc25a4 used in research accurately represents the biological characteristics of the endogenous protein.

ADP/ATP Exchange Mechanism

The fundamental function of Slc25a4 is the exchange of ADP and ATP across the inner mitochondrial membrane. Recombinant mouse Slc25a4 reconstituted into unilamellar liposomes has been shown to mediate this exchange with an activity rate of approximately 3.49 ± 0.41 mmol/min/g, comparable to values measured in intact mitochondria . This exchange follows a strict 1:1 stoichiometry, where one molecule of ADP is transported in one direction while one molecule of ATP is transported in the opposite direction.

The transport mechanism involves conformational changes in the protein that alternately expose binding sites to either side of the membrane. The exchange process is electrogenic, as ATP carries an additional negative charge compared to ADP, resulting in a net movement of charge across the membrane with each exchange cycle. This process is tightly regulated and can be specifically inhibited by compounds such as bongkrekic acid and carboxyatractyloside, which bind to different conformational states of the protein and prevent the structural changes necessary for transport .

Research using recombinant Slc25a4 has enabled detailed analysis of the transport kinetics and the factors that influence exchange rates. Studies have revealed that the ADP/ATP exchange rate calculated from Magnesium Green (MgGr™) fluorescence measurements solely depends on the Slc25a4 content in liposomes, confirming the direct relationship between protein concentration and transport activity . This quantitative relationship provides valuable information about the intrinsic catalytic properties of the translocase independent of other cellular factors.

Interaction with Other Proteins

Recombinant Slc25a4 studies have revealed previously unrecognized interactions with other mitochondrial proteins, particularly components of the protein import machinery. The protein has been shown to interact with TIM23, a central component of the presequence translocase that mediates protein import into mitochondria . This interaction appears to be critical for the role of Slc25a4 in mitophagy regulation, as it allows the protein to influence TIM23 activity in response to changes in mitochondrial bioenergetic status.

Additionally, Slc25a4 interacts with TIM44, a protein known to regulate peptide import through the TIM23 complex . This interaction provides a mechanistic link between Slc25a4 and the modulation of protein translocation into mitochondria. Interestingly, disease-causing mutations in human ANT1 (A90D and A123D) disrupt binding to TIM44 and TIM23, consequently inhibiting mitophagy . These findings highlight how recombinant protein studies have expanded our understanding of Slc25a4 beyond its classical role in nucleotide exchange to include broader functions in mitochondrial regulation.

The interaction network of Slc25a4 also extends to proteins involved in the formation or regulation of the mitochondrial permeability transition pore (mPTP). Although the exact composition of this pore remains controversial, evidence suggests that Slc25a4 contributes to its function either as a structural component or as a regulatory factor . These protein-protein interactions represent important targets for future research using recombinant Slc25a4 to better understand the molecular mechanisms underlying mitochondrial responses to stress and damage.

Regulatory Mechanisms

Post-translational modifications represent another important regulatory layer. Although not specifically mentioned in the search results for mouse Slc25a4, studies on ANT proteins have identified modifications such as phosphorylation, acetylation, and oxidation that can alter transport properties and interactions with other proteins. Recombinant systems provide valuable tools for investigating how these modifications affect protein function under controlled conditions.

The dual functionality of Slc25a4 as both an ADP/ATP exchanger and a proton transporter introduces additional regulatory complexity. The proton transport activity requires free fatty acids as cofactors but does not transport them directly . This activity is inhibited by the protein's ADP/ATP antiporter function, suggesting an intricate regulatory mechanism that balances energy production (ATP synthesis) and energy dissipation (thermogenesis) based on cellular needs . The ability to study these competing functions using purified recombinant protein in defined membrane environments offers unique insights into the molecular switches that govern mitochondrial energy distribution.

In Vitro Studies and Assays

Recombinant mouse Slc25a4 serves as a valuable tool for in vitro studies aimed at understanding the fundamental properties and functions of this important mitochondrial carrier. One significant advantage of using recombinant protein is the ability to precisely control experimental conditions and isolate the specific activity of Slc25a4 from other cellular components that might influence its behavior. This controlled environment allows researchers to directly attribute observed effects to the protein itself, providing clearer insights into its intrinsic properties.

In vitro assays using recombinant Slc25a4 include studies of binding affinities for various substrates and inhibitors, investigation of conformational changes during the transport cycle, and characterization of the effects of pH, membrane potential, and other physical parameters on transport activity. The protein can also be used to screen for novel modulators of mitochondrial transport, potentially leading to the development of compounds with therapeutic applications in mitochondrial disorders.

An important application involves the reconstitution of recombinant Slc25a4 into artificial membrane systems such as liposomes. This approach allows for the detailed investigation of transport mechanisms in a simplified environment that nevertheless retains the essential features required for protein function. As noted in the search results, this model system enables direct measurement of ADP/ATP exchange rates that are specifically dependent on Slc25a4 activity .

ELISA-Based Detection

Commercial ELISA kits for mouse Slc25a4 measurement represent a significant application of recombinant protein technology in research and clinical settings. These kits typically use antibodies generated against recombinant Slc25a4 to detect and quantify the protein in various biological samples. According to the search results, the Mouse ADP/ATP Translocase 1 (Slc25a4) ELISA Kit is designed for the precise measurement of Slc25a4 levels in mouse samples, including serum, plasma, and cell culture supernatants .

The sandwich enzyme immunoassay technique employed in these kits relies on antibodies specific for mouse Slc25a4 that have been pre-coated onto microplates . Standards and samples are added to the wells, allowing any Slc25a4 present to bind to the immobilized antibody. After washing, a detection antibody specific for Slc25a4 is added, followed by an enzyme conjugate and substrate solution that develops color in proportion to the amount of Slc25a4 bound in the initial step .

Table 1: Characteristics of the Mouse ADP/ATP translocase 1 (Slc25a4) ELISA Kit

These ELISA kits offer exceptional sensitivity and specificity, with detection ranges typically from 0.156-10 ng/mL and sensitivity around 0.067 ng/mL . This high performance enables researchers to accurately measure Slc25a4 levels in experimental settings, providing valuable data for studies of mitochondrial function, disease mechanisms, and potential therapeutic interventions.

Liposome Reconstitution Studies

A particularly powerful application of recombinant mouse Slc25a4 involves its reconstitution into liposomes for functional transport studies. This approach overcomes the limitations of measuring carrier activity in intact cells or mitochondria, where multiple transporters and metabolic pathways can complicate the interpretation of results. In liposome systems, the experimental conditions can be precisely defined, and the transport activity can be directly attributed to the reconstituted Slc25a4 protein.

The search results describe a fluorescence-based method using Magnesium Green (MgGr™), a Mg²⁺-sensitive dye suitable for measurement in liposomes . This technique exploits the different binding affinities of Mg²⁺ for ATP and ADP to detect changes in their concentrations during transport. Proteoliposomes are filled with MgGr™, Mg²⁺, and ATP, and the addition of external ADP initiates ATP exchange with ADP through Slc25a4. This exchange leads to increased binding of Mg²⁺ to MgGr™, resulting in a time-dependent increase in fluorescence intensity that can be converted to ADP/ATP exchange rates .

Using this approach, researchers obtained an ADP/ATP exchange rate of 3.49 ± 0.41 mmol/min/g for recombinant ANT1 reconstituted into unilamellar liposomes, comparable to values measured in mitochondria using radioactivity assays . This fluorescence-based method provides a valuable alternative to radioactive techniques, which are expensive and require stringent precautions. The specific inhibition of exchange by bongkrekic acid and carboxyatractyloside confirms that the measured activity is indeed mediated by Slc25a4, validating the assay's specificity .

Investigation of Disease Mutations

Recombinant Slc25a4 provides an excellent platform for investigating the effects of disease-associated mutations on protein function. By introducing specific mutations into the recombinant protein and studying their impact on transport activity, protein stability, and interactions with other molecules, researchers can gain insights into the molecular mechanisms underlying mitochondrial disorders linked to SLC25A4 mutations.

The search results mention that human mutations in ANT1 (the human ortholog of mouse Slc25a4) have been associated with autosomal dominant progressive external ophthalmoplegia and familial hypertrophic cardiomyopathy . Specific mutations such as A90D and A123D have been shown to abrogate binding to TIM44 and TIM23 and inhibit mitophagy . In contrast, an ATP-binding mutant (K43E/R244E) retained the ability to interact with these proteins and rescue the suppression of TIM23 in cells lacking ANT1 .

These findings illustrate how recombinant protein studies can reveal the functional consequences of disease-causing mutations at the molecular level. Such information is crucial for understanding pathogenic mechanisms and potentially developing targeted therapeutic approaches. The ability to produce and characterize mutant forms of Slc25a4 in a controlled experimental system represents a powerful advantage of recombinant protein technology in biomedical research.

Mitophagy Regulation

One of the most surprising discoveries about Slc25a4 function, revealed through studies using recombinant proteins and genetic models, is its critical role in mitophagy regulation. Unexpectedly, this function is independent of its canonical activity as an ADP/ATP exchanger . Research has shown that the adenine nucleotide translocator (ANT) complex is required for mitophagy in multiple cell types, with genetic ablation of ANT paradoxically suppressing mitophagy despite the fact that pharmacological inhibition of ANT-mediated ADP/ATP exchange promotes it .

The mechanism underlying this role involves the interaction of Slc25a4 with the protein import machinery. Specifically, ANT is required for inhibition of the presequence translocase TIM23 in response to bioenergetic collapse, which leads to PINK1 stabilization—a key initial step in the mitophagy process . ANT modulates TIM23 indirectly via interaction with TIM44, a known regulator of peptide import through TIM23 . These molecular interactions position ANT as a sensor of mitochondrial energetic status that can trigger quality control mechanisms when energy production is compromised.

This regulatory function has significant implications for mitochondrial homeostasis and cellular health. Mice lacking ANT1 exhibit blunted mitophagy and consequent profound accumulation of aberrant mitochondria . This observation underscores the physiological importance of Slc25a4 beyond its role in energy exchange and highlights how disruption of this function can lead to mitochondrial dysfunction and potentially contribute to disease pathogenesis.

Implications in Disease Models

The multifunctional nature of Slc25a4 makes it a critical factor in various disease models, particularly those involving mitochondrial dysfunction. As mentioned earlier, mutations in the human SLC25A4 gene have been associated with several disorders, including progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, and mitochondrial DNA depletion syndrome 12A . These conditions typically manifest with features related to impaired energy metabolism, such as muscle weakness, exercise intolerance, and cardiomyopathy.

The search results specifically mention that disease-causing human mutations in ANT1 (A90D and A123D) abrogate binding to TIM44 and TIM23 and inhibit mitophagy . This finding provides a mechanistic link between specific mutations and pathological consequences, suggesting that impaired mitophagy and the resulting accumulation of damaged mitochondria may contribute to disease progression. This perspective expands our understanding of these disorders beyond simple bioenergetic deficits to include defects in mitochondrial quality control.

Research using recombinant Slc25a4 in disease models can help elucidate the specific molecular pathways disrupted by different mutations and identify potential points for therapeutic intervention. By characterizing how various mutations affect different functions of the protein—nucleotide transport, proton leakage, interactions with other proteins, or mitophagy regulation—researchers can develop more targeted approaches to address the underlying pathogenic mechanisms in SLC25A4-related disorders.

Therapeutic Potential

The diverse functions of Slc25a4 and its central role in mitochondrial physiology make it an intriguing target for therapeutic development. Recombinant mouse Slc25a4 provides a valuable tool for screening and characterizing compounds that might modulate its activity in ways beneficial for treating mitochondrial disorders. Such compounds could potentially enhance deficient functions or inhibit excessive activities depending on the specific pathological context.

For disorders associated with impaired mitophagy due to SLC25A4 mutations, approaches aimed at restoring or bypassing the mitophagy-promoting function of ANT might be beneficial. Alternatively, for conditions involving excessive mitochondrial permeability or inappropriate apoptosis, modulators that stabilize ANT in configurations less conducive to pore formation could offer therapeutic benefits. The ability to test such compounds using purified recombinant protein in controlled systems provides an efficient path for initial drug discovery efforts.

Beyond direct targeting of Slc25a4, understanding its regulatory networks and interaction partners opens additional avenues for therapeutic intervention. By identifying the molecular mechanisms through which Slc25a4 senses mitochondrial stress and communicates with quality control machinery, researchers might discover alternative targets within these pathways that could be modulated to achieve similar beneficial effects. This systems-level approach, facilitated by recombinant protein studies, holds promise for developing more comprehensive strategies to address the complex pathophysiology of mitochondrial disorders.